Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.16B | $2.16B | $2.51B | $2.28B | $1.26B | $879.5M | $1.38B | $1.47B | $1.32B | $1.14B | $1.42B |
| Operating expenses | — | $1.27B | $1.12B | $949.2M | $745.3M | $668.2M | $948.0M | $946.5M | $886.7M | $877.2M | $699.6M |
| Operating income | −$182.1M | $351.0M | $803.3M | — | — | — | — | — | — | — | — |
| EBITDAderived | $439.0M | $574.5M | $1.04B | — | — | — | — | — | — | — | — |
| Net income | −$153.2M | $286.4M | $655.9M | $467.0M | $34.1M | −$9.8M | $76.0M | $153.0M | $67.6M | $41.5M | $307.0M |
| Basic EPSper diluted share | -$2.98 | $9.65 | $19.91 | $13.41 | $0.99 | -$0.37 | $2.82 | $5.48 | $2.42 | $1.48 | $10.98 |
| Diluted EPSper diluted share | -$2.98 | $9.61 | $19.79 | $13.07 | $0.96 | -$0.37 | $2.81 | $5.38 | $2.40 | $1.48 | $10.98 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 19, 2026Form 4 | Klein Rosemary LSVP, CLO & Corp. Sec. | SellCommon stock, par value $0.01 per share | 5.0K | $110.62 | $553.1K | 53.7K |
| Mar 19, 2026Form 4 | Klein Rosemary LSVP, CLO & Corp. Sec. | SellCommon stock, par value $0.01 per share | 10.0K | $105.00 | $1.05M | 58.7K |
| Mar 18, 2026Form 4 | Brock James AExecutive Chair and CEO | SellCommon stock, par value $0.01 per share · indirect | 40.8K | $101.15 | $4.12M | 100.0K |
| Mar 17, 2026Form 4 | Rothka JohnChief Accounting Officer | SellCommon stock, par value $0.01 per share | 1.0K | $97.66 | $97.7K | 5.2K |
| Mar 10, 2026Form 4 | Rothka JohnChief Accounting Officer | SellCommon stock, par value $0.01 per share | 3.8K | $91.62 | $348.2K | 6.2K |